NASDAQ
0.81USD
+0.03 (+3.66%)
We have scored 16 news catalysts on Clearmind Medicine Inc. (CMND) over the past 12 months. The biggest single-day move next to one of them came Aug 13, 2026, when CMND closed +12.1%: “Clearmind Advances CMND-100 to Alcohol Use Disorder Patients After Achieving Primary Safety Endpoint”. Coverage across the window leans positive (average ticker sentiment +0.74). Most of the impact sits in short squeeze potential and price momentum.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
1.2M
P/E
—
EPS
—
Beta
-1.22
52W range
0.77-480
Day range
0.79–0.83
Open
0.80
Prev close
0.78
Volume
282.6K
Avg volume
1.7M
Dividend
0.00
IPO
2022-11-15
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Clearmind Medicine Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for CMND: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Clearmind Medicine Inc. is a pre-clinical biopharmaceutical company dedicated to pioneering the development of novel psychedelic-based treatments. Their primary goal is to address a variety of mental health and addiction challenges that currently lack adequate solutions. The company's research targets conditions such as alcohol use disorder (including problematic binge drinking), various eating disorders (like binge eating), depression, and other compulsive or "binge" behaviors. Founded in 2017, the company initially operated under the name Cyntar Ventures Inc. before officially rebranding as Clearmind Medicine Inc. in March 2021. Its operations are headquartered in Vancouver, Canada.
